Retentiojärjestelmän optimointi kartonkikoneella

Diplomityössä tutkittiin kartonkikoneen retentiojärjestelmää ja eri mahdollisuuksia retention ja vedenpoiston tehostamiseen. Tavoitteena oli parantaa etenkin runkokerroksen retentiota ja vedenpoistoa. Työssä testattiin kilpailevan kemikaalitoimittajan mikropartikkelia kartonkikoneella. Lisäksi runkokerroksessa testattiin retentiotärkkelyksen vaikutus kartongin palstaumislujuuteen, suoritettiin käytössä olevan mikropartikkelin annostuksen optimointi sekä testattiin alunan käyttöä retentioainesysteemin tehoaineena. Kirjallisuusosassa tarkasteltiin pinta- ja kolloidikemian perusteita, retentioainejärjestelmiä ja niissä käytettäviä kemikaaleja sekä retentioaineilla tehtävään flokkaukseen vaikuttavia tekijöitä. Laboratoriokokeilla tutkittiin kokeellisessa osassa eri mikropartikkelijärjestelmien toimivuutta kartonkikoneen eri kerroksien massoilla. Toimivimmaksi osoittautuneella mikropartikkelilla suoritettiin pilot-koeajo runkokerroksen massalla. Lisäksi suoritettiin toinen pilot-koeajo, jossa tutkittiin mikropartikkelin vaikutuksia saostuman aiheuttajana. Pilot-koeajoissa saavutettiin samat retentiotasot kuin referenssisysteemillä lähes puolet pienemmällä kemikaalin kulutuksella. Kartongin laatuominaisuuksista huokoisuus, formaatio ja AKD-liiman retentio muuttuivat viiraretention mukaan. Saostumakoeajossa ei todettu retentioaineen vaikuttavan saostumien syntyyn. Täyden mittakaavan koeajossa tarkoituksena oli testata kilpailevan mikropartikkelin toimivuus kartonkikoneella. Koeajossa etsittiin optimaalinen mikropartikkelin annostus eri kerroksiin. Pintakerroksen tuhkaretentio nousi hiukan ja vedenpoisto parani. Runko- ja taustakerroksessa saavutettiin samat retentiotasot sekä vedenpoistot. Samat retentiotasot saavutettiin n. 25 % pienemmällä mikropartikkelin kulutuksella. Kartongin laatuominaisuuksista seurattiin palstautumislujuutta, formaatiota ja AKD-liiman retentoitumista. Kartongin palstautumislujuus heikkeni. Vastaavasti runko- ja taustakerroksen AKD-liiman retentio oli hiukan korkeampi koeajetulla mikropartikkelilla. Formaatiossa ei tapahtunut merkittäviä muutoksia. Jatkokokeet tehtiin kartonkikoneen runkokerroksessa. Kokeissa todettiin retentiotärkkelyksen vaikuttavan kartongin palstautumislujuuteen. Käytössä olevan mikropartikkelin annostelun optimointikokeissa ei saavutettu parannusta retentioon eikä vedenpoistoon. Mikropartikkelilla saavutetaan tietty retentiotaso, jonka jälkeen sillä ei ole enää vaikutusta retentiotasoon. Alunan annostelukokeissa ei alle yksi kg/t annosmäärällä ole vaikutusta retentioon ja vedenpoistoon.

Partnering in the Dynamic Environment: The Role of Trust in Asymmetric Technology Partnership Formation

The purpose of this study was to increase the understanding of the role and nature of trust in asymmetric technology partnership formation. In the knowledge-based "learning race" knowledge is considered as a primary source for competitive advantage. In the emerging ICT sector the high pace of technological change, the convergence of technologies and industries as well as the increasing complexity and uncertainty have forced even the largest players to seek cooperation for complementary knowledge and capabilities. Small technology firms need the complementary resources and legitimacy of the large firms to grow and compete in the global market place. Most of the earlier research indicates, however, that partnerships with asymmetric size, managerial resources and cultures have failed. A basic assumption supported by earlier research was that trust is a critical factor in asymmetric technology partnership formation. Asymmetric technology partnership formation is a dynamic and multi-dimensional process, and consequently a holistic research approach was selected. Research issue was approached from different levels: the individual decision-maker, the firm and the relationship between the parties. Also the impact of the dynamic environment and technology content was analyzed. A multitheoretical approach and a qualitative research method with in-depth interviews in five large ICT companies and eight small ICT companies enabled a holistic and rich view of the research issue. Study contributes on the scarce understanding on the nature and evolution of trust in asymmetric technology partnership formation. It sheds also light on the specific nature of asymmetric technology partnerships. The partnerships were found to be tentative and the diverse strategic intent of small and large technology firms appeared as a major challenge. The role of the boundary spanner was highlighted as a possibility to match the incompatible organizational cultures. A shared vision was found to be a pre-condition for individual-based fast trust leading to intuitive decision-making and experimentation. The relationships were tentative and they were continuously re-evaluated through the key actors' sense making of the technology content, asymmetry and the dynamic environment. A multi-dimensional conceptualization for trust was created and propositions on the role and nature of trust for further research are given. The purpose of this study was to increase the understanding of the role and nature of trust in asymmetric technology partnership formation. In the knowledge-based "learning race" knowledge is considered as a primary source for competitive advantage. In the emerging ICT sector the high pace of technological change, the convergence of technologies and industries as well as the increasing complexity and uncertainty have forced even the largest players to seek cooperation for complementary knowledge and capabilities. Small technology firms need the complementary resources and legitimacy of the large firms to grow and compete in the global market place. Most of the earlier research indicates, however, that partnerships with asymmetric size, managerial resources and cultures have failed. A basic assumption supported by earlier research was that trust is a critical factor in asymmetric technology partnership formation. Asymmetric technology partnership formation is a dynamic and multi-dimensional process, and consequently a holistic research approach was selected. Research issue was approached from different levels: the individual decision-maker, the firm and the relationship between the parties. Also the impact of the dynamic environment and technology content was analyzed. A multitheoretical approach and a qualitative research method with in-depth interviews in five large ICT companies and eight small ICT companies enabled a holistic and rich view of the research issue. Study contributes on the scarce understanding on the nature and evolution of trust in asymmetric technology partnership formation. It sheds also light on the specific nature of asymmetric technology partnerships. The partnerships were found to be tentative and the diverse strategic intent of small and large technology firms appeared as a major challenge. The role of the boundary spanner was highlighted as a possibility to match the incompatible organizational cultures. A shared vision was found to be a pre-condition for individual-based fast trust leading to intuitive decision-making and experimentation. The relationships were tentative and they were continuously re-evaluated through the key actors' sense making of the technology content, asymmetry and the dynamic environment. A multi-dimensional conceptualization for trust was created and propositions on the role and nature of trust for further research are given.

Free PAPP-A: a Novel Marker in Acute Coronary Syndrome Patients

In recent years, one important objective of cardiovascular research has been to find new markers that would improve the risk stratification and diagnosis of patients presenting with symptoms of acute coronary syndrome (ACS). Pregnancy-associated plasma protein A (PAPP-A) is a large metalloproteinase involved in insulin-like growth factor signalling. It is expressed in various tissues and seems to be involved in many physiological and pathological processes, such as folliculogenesis, bone formation, wound healing, pregnancy and atherosclerosis. The aim of this thesis was to investigate PAPP-A in ACS patients. Circulating concentrations of PAPP-A had been previously shown to be elevated in ACS. In this study it was revealed that the form of PAPP-A causing this elevation was the free noncomplexed PAPP-A. Thus, the form of PAPP-A in the circulation of ACS patients differed from the complexed PAPP-A form abundantly present in the circulation during pregnancy. A point-of-care method based on time-resolved immunofluorometric assays was developed, which enabled the rapid detection of free PAPP-A. The method was found to perform well with serum and heparin plasma samples as well as with heparinized whole blood samples. With this method the concentrations of free PAPP-A in healthy individuals were shown to be negligible. When the clinical performance of the method was evaluated with serum samples from ACS patients, it was shown that the free PAPP-A concentration in the admission sample was an independent predictor of myocardial infarction and death. Moreover, as a prognostic marker, free PAPP-A was revealed to be superior to total PAPPA, i.e. the combination of free and complexed PAPP-A, which has been measured by the other groups in this field. As heparin products are widely used as medication in ACS patients, the effect of heparin products on free PAPP-A molecule and circulating concentrations were also investigated in this study. It was shown that intravenous administration of low molecular weight or unfractionated heparin elicits a rapid release of free PAPP-A into the circulation in haemodialysis patients and patients undergoing angiography. Moreover, the interaction between PAPP-A and heparin was confirmed in gel filtration studies. Importantly, the patients included in the clinical evaluation of the free PAPP-A detection method developed had not received any heparin product medication before the admission sample and thus the results were not affected by the heparin effect. In conclusion, free PAPP-A was identified as a novel marker associated with ACS. The point-of-care methods developed enable rapid detection of this molecule which predicts adverse outcome when measured in the admission sample of ACS patients. However, the effect revealed of heparin products on circulating PAPP-A concentrations should be acknowledged when further studies are conducted related to free or total PAPP-A in ACS.